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Hypothalamic Fatty Acids and
Ketone Bodies Sensing and Role of
FAT/CD36 in the Regulation of Food
Intake
Christelle Le Foll*
Institute of Veterinary Physiology, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland
The obesity and type-2 diabetes epidemic is escalating and represents one of the
costliest biomedical challenges confronting modern society. Moreover, the increasing
consumption of high fat food is often correlated with an increase in body mass index.
In people predisposed to be obese or already obese, the impaired ability of the brain
to monitor and respond to alterations in fatty acid (FA) metabolism is increasingly
recognized as playing a role in the pathophysiological development of these disorders.
The brain senses and regulates metabolism using highly specialized nutrient-sensing
neurons located mainly in the hypothalamus. The same neurons are able to detect
variation in the extracellular levels of glucose, FA and ketone bodies as a way to monitor
nutrient availability and to alter its own activity. In addition, glial cells such as astrocytes
create major connections to neurons and form a tight relationship to closely regulate
nutrient uptake and metabolism. This review will examine the different pathways by
which neurons are able to detect free fatty acids (FFA) to alter its activity and how high
fat diet (HFD)-astrocytes induced ketone bodies production interplays with neuronal FA
sensing. The role of HFD-induced inflammation and how FA modulate the reward system
will also be investigated here.
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Over the past decade, the research on FA and how it can modulate neuronal signaling has
grown substantially leading us to discover the role of cells that were under-studied until
now, the astrocytes. This review will examine in detail how FA and its metabolites, such as
ketone bodies, are able to alter astrocytes metabolism and neuronal activity to control food
intake and energy homeostasis. Moreover, while FA can be uptaken directly from the blood
stream and act on hypothalamic neurons through the FA transporter/receptor FAT/CD36,
triglycerides/triacylglyceride (TG) are also found in the brain in lipoproteins. When TG are released
by the lipoprotein lipase (LPL), subsequent FA can then alter neuronal activity. These FA, when in
excess, are metabolized by astrocytes into ketone bodies to modulate neuronal activity. In addition
to food intake and energy homeostasis, FA can also exert rewarding properties.
FATTY ACIDS BRAIN UPTAKE AND TRANSPORT
Fatty acid are first classified by their carbon (C) chain length: short-chain (<12 C), medium-length
(between 12 and 18 C) and long-chain (>18 C). Then they are further classified by the
number of double bonds: saturated (no double bonds), monounsaturated (one double bond)
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and polyunsaturated (>one double bond) (Table 1). The
proportion of each FA absorbed and metabolized by the body
depends on our food sources and dietary intake. While saturated
FA have been associated with various deleterious effects on
metabolism (Vessby, 2003) and cardio-vascular function (Mente
et al., 2017), mono- and polyunsaturated FA present beneficial
properties (Bellenger et al., 2019). Dietary fat is mainly composed
of TG, cholesterols ester and phospholipids (Thomson et al.,
1989). Briefly, once digested by enzymes in the mouth, stomach
and small intestine, TG are broken down into smaller particles
such as monoglycerides, FFA and cholesterol; these are then
reorganized in micelles and uptaken by intestinal cells (Ramirez
et al., 2001; Mu and Hoy, 2004) and released into chylomicrons
in the blood stream to reach muscle, adipose tissue and the liver.
To penetrate the brain, circulating FA need to cross the blood
brain barrier (BBB). The BBB is a complex structure composed of
endothelial cells that line the vessel wall, pericytes, astrocytes foot
processes and a basal lamina (Engelhardt et al., 2014; Daneman
and Prat, 2015). Together with neurons and microglia, the BBB
forms the neurovascular unit with astrocytes providing a cellular
link to adjacent neurons (Abbott et al., 2010; Banks, 2019).
Endothelial cells of the BBB protect the brain against potentially
dangerous substances through tight junctions. Additionally, most
brains areas lack fenestrations, limiting paracellular passage
(Brightman and Reese, 1969; Fenstermacher et al., 1988; Hawkins
and Davis, 2005). To bypass the BBB, FA can passively diffuse
through the BBB or are specifically transported at the membrane
of brain capillaries (Hamilton, 1999).
Thus, FA can diffuse passively at the outer layer of the plasma
membrane and this diffusion is dependent upon the lipophilic
properties of the FA (Hamilton, 1999). Short-chain FA display
the highest permeability while FA with a carbon chain over 12
C cannot directly penetrate the BBB because of their ionic charge
(Levin, 1980). To diffuse rapidly across the plasma membrane,
long-chain FA such as palmitic acid (PA), arachidonic acid (AA)
and docosahexaenoic acid (DHA), which form a large proportion
of the brain FA, need to be first transformed into a non-ionized
TABLE 1 | Name and classification of the most common dietary fatty acids (FA).
Name Number of
carbon: Number
of double bonds
Saturated FA
Octanoic acid C8:0
Lauric acid C12:0
Palmitic acid (PA) C16:0
Stearic acid C18:0
Arachidic acid C20:0
Unsaturated FA
Palmitoleic acid C16:1
Oleic acid (OA) C18:1
Linoleic acid (LA) C18:2
Arachidonic acid (AA) C20:4
Eicosapentaenoic acid (EPA) C20:5
Docosahexaenoic acid (DHA) C22:6
form. This then allows a mechanism of “flip and flop,” which is
independent of transport proteins (Hamilton et al., 2002, 2007;
Kamp et al., 2003). In addition, the passage of these long chain
FA is greatly facilitated when combined to albumin. In awake rats
and using radioactive FA, Rapoport et al. (1997) have shown that
when FA are first combined to albumin, they are rapidly uptaken
and incorporated into membrane phospholipids. Similarly the
carotid perfusion of 14C palmitic combined to albumin showed
its rapid incorporation (less than 45 s) to the FA in the rat cerebral
membrane phospholipids (Smith and Nagura, 2001). On the
other hand, FA can use specific saturable transporters which have
been located at the surface of the human and rodent endothelial
cells (Mitchell and Hatch, 2011; Mitchell et al., 2011; Pelerin
et al., 2014). These different transporters have been shown to be
expressed in brain endothelial cells: FA transport protein (FATP)
1 and 4 (Fitscher et al., 1998; Ochiai et al., 2017), FAT/CD36
(Abumrad et al., 2005) and intracellular FA binding proteins 1-7
(FABP) (Zimmerman et al., 2001).
In human brain microvessel endothelial cells, FAT/CD36
performs the majority of the transport (Mitchell et al., 2011).
A similar level of brain PUFA was shown in CD36 knockout mice
vs. WT mice suggesting that CD36 is not the only mechanism
maintaining brain PUFA levels in these KO mice (Song et al.,
2010). This was further confirmed by Pelerin et al. (2014)
who quantified the different transporter in the BBB of the rat
cerebral cortex with FATP4 being the most abundant. FATPs
are bifunctional proteins (uptake and acylation) and do not
display any affinity for a specific type of FA (Schaffer and Lodish,
1994; Stahl et al., 1999). These FATPs are well-conserved across
species and have two domains, the ATP binding domain and the
FA binding domain (DiRusso et al., 2008). FATPs are coupled
to a long-chain acyl-coA synthetase which transforms FA into
FA acyl-CoA to be directly metabolized by the adjacent cells
(Hall et al., 2003). To mediate FA uptake and metabolism, the
binding of ATP is necessary and whether the change in ATP/AMP
ratio affect the adjacent neuron and astrocyte activity remains
to be determined.
FAT/CD36 binds saturated and unsaturated FA in the
nanomolar concentration range (Baillie et al., 1996) and has been
shown to have a higher affinity to long-chain FA (>18 C) at least
in mice enterocytes (Drover et al., 2008). The exact mechanism
by which it transports FA still remains to be elucidated. FABP1,
3, 5, and 6 are also expressed in other tissues than the brain, such
as the liver and intestine, while FABP7 is specifically expressed
in the rat brain (Veerkamp and Maatman, 1995; Glatz and van
der Vusse, 1996). FABP5 is highly expressed by human and
mice endothelial cells (Masouye et al., 1997; Pan et al., 2015).
Using cell line and human brain FABPs constructs, long-chain
unsaturated FA such as oleic acid (OA) and AA seem to present a
higher affinity compared to PA (Zimmerman et al., 2001). When
studying these transport processes in rodents, it is important
to notice that their expression is variable depending on the
metabolic status and the species. For example, rats fed with
n-3 FA enriched diet had an increase in brain microvessels
FABP7 compared to chow-fed rats and brain FA transporters
were decreased in 9-week old rats compared to 3-week old rats
(Pelerin et al., 2014).
Frontiers in Physiology | www.frontiersin.org 2 August 2019 | Volume 10 | Article 1036
fphys-10-01036 August 13, 2019 Time: 16:0 # 3
Le Foll Hypothalamic Role of CD36
While these transport mechanisms are important to brain
areas with a BBB, circumventricular organs (CVO) which
are located at the interface between the brain and the
periphery present a highly fenestrated BBB. These sensory CVOs
are: subfornical organ; organum vasculosum of the lamina
terminalis; area postrema; median eminence. In the medio-basal
hypothalamus, a crucial area in the control of food intake, the
ARC also presents a “leaky” BBB due to the presence of tanycytes
and fenestrated capillaries (Dehouck et al., 2014; Banks, 2019).
In these regions, the lesser number of tight junctions between
endothelial cells allows the penetration of molecules (Bennett
et al., 2009). The uptake of FA in these regions has been scarcely
studied (Banks et al., 1997) and one can assume that the presence
of fenestrated endothelial cells facilitates the passage of FA.
BRAIN FA RECEPTORS AND
MODULATION OF NEURONAL ACTIVITY
While during fasting, FFA levels are increased due to lipolysis,
the elevation of FFA during HFD feeding stimulate glycolysis
and lipogenesis. Metabolic sensing neurons located in the
medio-basal hypothalamus monitor the variation of FFA, glucose
and insulin levels along with other gut hormones to alter their
activity and act on diverse peripheral mechanisms involved in the
control of food intake. While short-term HFD feeding triggers
food satiety, long-term HFD dysregulates these processes and
food intake control is altered.
Hypothalamic Nutrient Sensing and
CD36-Mediated FA Neuronal Sensing
In the 1950s, Jean Mayer first hypothesized that neurons in the
hypothalamus were able to sense a change in glucose oxidation as
a mean of controlling feeding (Mayer, 1953). Later, Oomura et al.
(1964) identified these neurons and named them glucosensing
neurons. Indeed, the hypothalamus contains “metabolic sensing
neurons” which monitor ambient levels of substrates such as
glucose, FA (Le Foll et al., 2009b) and ketone bodies (Le Foll
and Levin, 2016) but also of hormones such as leptin (Irani
et al., 2008) and amylin (Davidowa et al., 2004). These neurons
alter their membrane potential and activity in response to these
stimuli resulting in the activation or release of a variety of
substrate transporters, ion channels and enzymes (Anand et al.,
1964; Oomura et al., 1964; Levin et al., 2006; Migrenne et al.,
2006; Wang et al., 2006; Levin, 2007; Jo et al., 2009; Le Foll
et al., 2009a,b, 2013, 2014, 2015a; Blouet and Schwartz, 2010;
Chari et al., 2010) all these factors contribute to the control of
feeding, thermogenesis and other facets of energy and glucose
homeostasis (Mayer, 1953; Oomura et al., 1975; Levin et al.,
2006; Migrenne et al., 2006; Wang et al., 2006; Levin, 2007;
Jo et al., 2009; Blouet and Schwartz, 2010; Chari et al., 2010).
These specialized neurons are clustered in brain areas such as
the arcuate nucleus (ARC) (Muroya et al., 1999; Ibrahim et al.,
2001; Wang et al., 2006; Le Foll et al., 2009b), ventromedial
hypothalamic nucleus (VMN) (Song et al., 2001; Dunn-Meynell
et al., 2002; Kang et al., 2004; Levin et al., 2004; Le Foll et al.,
2009b), areas involved in energy and glucose homeostasis and
neuroendocrine regulation. Many studies have demonstrated that
FA sensing neurons are present in the VMN and ARC (Migrenne
et al., 2006; Wang et al., 2006; Jo et al., 2009). Among the ARC
neurons, the role of FA on POMC and NPY/AgRP neurons
has been the most studied. POMC and NPY/AgRP neurons
belong to the melanocortin system (Joly-Amado et al., 2014).
POMC neurons release the catabolic neuropeptide, α-melanocyte
stimulating hormone (αMSH) which acts on melanocortin 3 and
4 receptors (MCR3/4) to subsequently reduce food intake and
increase energy expenditure via thermogenesis (Balthasar et al.,
2005). AgRP serves as a potent endogenous antagonist at the
MCR3/4. NPY/AgRP neurons synapse onto POMC neurons to
provide inhibitory action via release of NPY onto NPY receptor
type 2 (Y2) and gamma-aminobutyric acid (GABA), further
supporting a tightly regulated neuronal network [for review see
Morton et al. (2006)].
Studies by Jo et al. (2009) demonstrated that in mice,
40% of proopiomelanocortin (POMC) neurons in the ARC
sense long-chain FA via β-oxidation and closure of the KATP
channel. OA depolarizes and increases firing rate of POMC cells
during patch-clamping and this depolarization is concentration
dependent while octanoic acid, a short chain saturated FA does
not induce the same effect in these same neurons. Out of
these POMC FA sensing neurons, 60% were excited by glucose.
Opposite to POMC, OA is unable to depolarize AgRP neurons
(Jo et al., 2009) even though Flick et al. showed later on
that PA increased NPY mRNA in hypothalamic cell line (Fick
et al., 2011). When mice were fed chow or HFD for 2 weeks,
HFD itself altered the neurons excitability but their response
to OA was similar in both groups. Further Diano et al. (2011)
observed that, in response to reactive oxygen species production
(ROS), HFD-feeding decreased POMC firing which in turn
increased food intake (Paeger et al., 2017). The inactivation in
POMC neurons of the apoptosis–inducing factor, a factor that
is involved in the mitochondrial respiratory chain, increased
neurons FA utilization and ROS production increasing POMC
firing rate (Timper et al., 2018). More recently, a study showed
that a systemic infusion of PA increased POMC neurons and
PC1/3 mRNA hypothalamic expression. The inhibition of PC1/3
promoted caloric intake and weight gain in an obesity resistant
mouse model (Souza et al., 2016). Furthermore, PA also increased
POMC transcript in human hypothalamic neurons and this effect
was found with PA only (Tse and Belsham, 2018; Razolli et al.,
2019). On the contrary, rats injected intracerebroventricularly
with different FA, only OA and DHA (and not PA), were
able to increase POMC mRNA expression. The use of an
MCR4 antagonist completely reversed the anorectic effect of OA
(Schwinkendorf et al., 2011). Taken together, these results suggest
that POMC neurons may mediate the anorexigenic effects of OA.
These studies demonstrate that FA can alter neuronal activity and
that these effects are FA-specific.
While these above studies have used hypothalamic cell
line and in vivo FA infusion, nanomolar concentrations
of OA have been shown to either excite or inhibit 43
and 29% of VMN 3-week old rats dissociated primary
neurons (Le Foll et al., 2009a). Pharmacological studies were
then undertaken and Ca2+ imaging of dissociated primary
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neurons as a surrogate for changes in neuronal activity was
measured. The exclusion one by one of each component of
the classical β-oxidative FA intracellular metabolic pathway
such as carnitine palmitoyltransferase 1 (CPT1), acetyl-CoA
carboxylase (ACC) and KATP channel (Le Foll et al., 2009a)
demonstrated that FAT/CD36 is the principal mediator of FA in
modulating neuronal activity in the ventromedial hypothalamus
(VMH = ARC + VMN) of mice and rats. Indeed only 20% of
neuronal FA sensing is mediated by these classical intracellular
pathways whereas 50% is mediated by FAT/CD36 (Le Foll et al.,
2009a). FAT/CD36 is located throughout the brain, but its
function in relation to food intake and energy homeostasis has
mainly been studied in the medio-basal hypothalamus of rodents
(Le Foll et al., 2009a, 2013, 2015a).
The depletion of FAT/CD36 in the ARC and VMN neurons
using an AAV shRNA did not affect the glucosensing properties
of 3-week old rats primary dissociated neurons, however, OA
excitatory effect on VMH neurons was reduced by 50% and
its inhibitory effect by 75% (Le Foll et al., 2013). On the
other hand, the complete loss of CD36 in CD36KO mice
affected the glucosensing properties by decreasing glucokinase,
a critical regulator of glucosensing (Kang et al., 2004).
CD36 KO mouse FA sensing neuronal response was also
different than what was observed in rat primary neurons.
Indeed, CD36 KO mice had fewer inhibitory FA sensing
neurons, but the depletion of CD36 did not modify the
excitatory properties of these neurons. These discrepancies
could result from species difference and/or the depletion’s
method. On one side CD36 was depleted postnatally using
an AAV, on the other side CD36 whole-body KO resulted
from a germ cell deletion where both plastic changes during
development leading to compensatory mechanisms and overall
altered energy and glucose homeostasis can occur. In addition,
patients with depletion of the CD36 gene are often diagnosed
with hyperinsulinism and are prone to metabolic syndrome
underlining the importance of FAT/CD36 in the control of
metabolism (Love-Gregory and Abumrad, 2011).
Similar to taste buds, it is hypothesized that CD36-mediated
FA-induced neuronal activation increases [Ca2+]i by recruiting
Ca2+ from the endoplasmic reticulum pool which opens
store-operated calcium channels (Abdoul-Azize et al., 2014);
more experiments are needed, however, to validate this
hypothesis. CD36-mediated FA sensing occurs specifically in
ARC and VMN glucosensing neurons highlighting the idea that
these metabolic sensing neurons integrate signals from metabolic
substrates as well as hormones and neural inputs to regulate their
activity (Levin et al., 2011).
While the important role for CD36 in mediating neuronal FA
sensing in the VMH was established in vitro, its crucial function
in the control of food intake, long-term energy and glucose
homeostasis was further assessed. The depletion of CD36 using
an AAV shRNA in the VMH of weanling Sprague-Dawley rats fed
for 9 weeks 45% HFD increased leptin levels and subcutaneous
fat and induced insulin-resistance without overall effect on food
intake and body weight (Le Foll et al., 2013, 2015a). Since both
obesity and type 2 diabetes have major comorbidities that make
it imperative to understand the underlying mechanisms that
control food intake and regulate energy and glucose homeostasis,
the role of CD36 was further assessed in a rodent model of
human obesity. Diet induced obese (DIO) and diet resistant (DR)
rats are selectively bred to reproduce the polygenic alterations
inherent to human obesity (Levin and Strack, 2008). These rats
are selectively bred to produce DIO or to remain DR when fed
a high energy (HE, 31% fat-24% sucrose as% of total energy
source) diet. On low-fat chow diet, DIO rats are larger, but
not fatter, than DR rats. When fed HE diet, DIO rats rapidly
develop an insulin-resistance and become obese (Levin et al.,
1997; Levin and Dunn-Meynell, 2000, 2002). The depletion of
CD36 in the VMH of DIO rats fed 45% HFD increased their
food intake and weight gain compared to AAV control DIO
rats, while CD36- depleted DR rats gained less weight than DR
AAV controls. VMH CD36 depletion increased inguinal fat pad
weights and leptin levels in DIO and DR rats. Even though
CD36-depleted DR rats became as obese as DIO AAV controls,
only DIO CD36 depleted rats became insulin-resistant on a
45% HFD as shown by a glucose intolerance and by elevated
insulin levels during the oral glucose tolerance test. In addition,
liver TG were drastically increased in DIO rats injected with
AAV CD36 shRNA. All together, these results demonstrate that
VMH CD36- FA sensing neurons are of the most importance
in the control of food intake and the regulation of energy and
glucose homeostasis as well as fat deposition in DIO and DR rats
(Le Foll et al., 2009b, 2015a).
In addition to FAT/CD36, other pathways can alter neuronal
FA sensing. Indeed, manipulating brain FA oxidation itself
can also alter food intake (Clegg et al., 2002; Obici et al.,
2003; Pocai et al., 2006; Aja et al., 2007). Earlier studies
have shown that the hypothalamic levels of long-chain fatty
acyl-CoAs can be increased by enhanced esterification of
circulating or central lipids (Obici et al., 2002; Lam et al.,
2005) or by the local inhibition of lipid oxidation (Obici et al.,
2003). These interventions result in a marked inhibition of
liver gluconeogenesis and a decrease in food intake (Obici
et al., 2002, 2003; Lam et al., 2005; Pocai et al., 2006).
Further, the inhibition of FA synthase and the stimulation of
FA mitochondrial metabolism through CPT1 decreased food
intake and body weight in mice and rats (Aja et al., 2006,
2007). However, more recent studies suggest that the inhibition
or stimulation of these FA metabolic pathways could affect
astrocytes’ metabolism rather than neurons since astrocytes
are the major source of brain FA oxidation (Edmond, 1992)
(see section “Astrocyte-Neuronal Coupling and Regulation
of Food Intake”).
Role of Lipoprotein Lipase in Mediating
Neuronal FA Sensing
While research has focused on the role of circulating FA coming
from the periphery and crossing the BBB, lipoproteins are also
found in the brain and these are produced within the central
system and contribute to the brain lipid sensing (Cruciani-
Guglielmacci and Magnan, 2017; Gao et al., 2017b). These
lipoproteins are the main carrier for TG to be transported
into the brain; lipoproteins are TG-enriched particles and are
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mainly found in the brain under the HDL form (Wang and
Eckel, 2014). Several lipases are expressed in the brain and can
locally hydrolyze these particles to release TG (Paradis et al.,
2004). Similar to FFA and other nutrients, daily variation of
TG level has been detected in the brain (Ruge et al., 2009)
indicating that TG or their metabolic products are able to inform
brain cells about the body nutrient status and participate in the
control of energy homeostasis. LPL mRNA has been detected
in neurons and astrocytes in the brain (Wang et al., 2011;
Wang and Eckel, 2012) and LPL has been demonstrated to be
the key enzyme that metabolize TG into FA and its activity
is regulated by nutrients and hormones in a tissue-specific
manner (Wang et al., 2011; Wang and Eckel, 2012). The
depletion of LPL in the VMH induced body weight gain in
mice associated to hyperinsulinemia and glucose intolerance as
well as a decrease in locomotor activity (Laperrousaz et al.,
2017). This suggests that the absence of LPL-mediated FA
sensing in the brain may lead to deregulation of energy balance
(Laperrousaz et al., 2017). It has also been shown that the
depletion of LPL in the dorsal hippocampus increased body
weight gain without affecting food intake in both mice and
rats (Picard et al., 2014). This increase in body weight gain
was associated with a decrease in locomotor activity and energy
expenditure and as well as an increase in parasympathetic
nervous activity (Picard et al., 2014). Last, the specific depletion
of LPL in astrocytes reduced the accumulation of lipid droplets
in these cells, increased body weight and induced a glucose
intolerance in these high-fat diet fed-mice (Gao et al., 2017c).
Together these studies seem to indicate that LPL is a major
key enzyme regulating the hydrolysis of TG from lipoprotein
thus providing FA which can then be detected by neurons
and glial cells.
G-Protein Receptors GPR120 and GPR40
Recently, other FA receptors have been discovered in the
brain. These G-protein receptors, GPR120 and GPR40, have
been found on neurons and microglia (Cintra et al., 2012;
Dragano et al., 2017) in brain areas such as the ARC,
ventral tegmental area (VTA), nucleus accumbens (NAc) and
hippocampus (Auguste et al., 2016), although in much lower
levels than in the intestine or the adipose tissue. These receptors
are stimulated by long-chain FA including omega-3 FA such
as eicosapentaenoic acid (EPA) and docosapentaenoic acid
(DHA). Hirasawa et al. (2005) showed that the stimulation
of GPR120 by long-chain FA activate ERK cascade which
suggests interactions with the Gαq family of G proteins.
Depletion studies of GPR120 with a lentivirus in mice did
not alter body weight or food intake and no change in
glucose tolerance was detected (Dragano et al., 2017). The
injection of the GPR120 agonist decreased food intake acutely
in chow-fed rats and suppressed the rewarding effect of high-
fat high-sugar diet as well as anxiety-like behavior (Auguste
et al., 2016). However, the activation of GPR40 with an
agonist did not affect food intake (Auguste et al., 2016).
It also appears that the activation of GPR120 produces
anti-inflammatory effects at least in immortalized hypothalamic
neurons (Wellhauser and Belsham, 2014).
ASTROCYTE-NEURONAL COUPLING
AND REGULATION OF FOOD INTAKE
While the focus for the past decades has been on the role
of metabolic sensing neurons, emerging data have shown that
glial cells and particularly astrocytes can also play an important
role in detecting and metabolizing FA to modulate energy
homeostasis. Indeed, astrocytes, which first function provide
metabolic support for neurons (Edmond, 1992; Yi et al., 2011),
have been understudied until recently. Astrocyte foot processes
are directly in contact with brain microvessels and thus are the
first cells encountered by nutrients entering the brain (Abbott
et al., 1992; Tsacopoulos and Magistretti, 1996). Astrocytes have
several important metabolic functions (Pellerin and Magistretti,
1994; Magistretti and Pellerin, 1999; Perea et al., 2009, 2014;
Araque et al., 2014) such as glycogen storage and lactate
production to support neuronal metabolism, especially during
enhanced neuronal activity (Pellerin et al., 1998; Pellerin and
Magistretti, 2012). In addition, astrocytes can also release and
transport neurotransmitters (Allen, 2014; Khakh and Sofroniew,
2015), regulate ion concentration and regulate blood flow
(MacVicar and Newman, 2015) and act as glucose sensors
(Garcia-Caceres et al., 2016).
Production of Ketones by Astrocytes and
Role of Tanycytes
During fasting period (see review Cahill, 2006), exogenous
glucose levels decrease, inducing liver glycogenolysis and adipose
tissue lipolysis (DeFronzo, 2004; Moore et al., 2012; Sharabi et al.,
2015). Once glycogen stores are depleted, the liver first generates
glucose through gluconeogenesis to fuel other tissues (Zhang
et al., 2018). If the fasting condition persists, ketone bodies
(β-hydroxybutyrate (βOHB) and acetoacetate) are generated
by the liver from FA through mitochondrial β-oxidation and
ketogenesis (Rui, 2014). Ketone bodies can also be produced
by the intestine and stimulate local visceral afferents to regulate
food intake (Karimian Azari et al., 2013; Azari et al., 2014).
These ketones bodies, as well as FA, can be transported into
the brain to serve as an alternate energy source during fasting
(Rui, 2014). Many studies have assessed the role of ketone bodies
on food intake by either infusing ketones (Park et al., 2011)
or using ketogenic diets (Johnston et al., 2006; Dashti et al.,
2007; Park et al., 2011). Ketogenic diets which are rich in fat
and low in carbohydrates, have been of great interest recently.
Briefly, dietary TG are digested by gastrointestinal lipase to
generate FA, which are then metabolized by the liver through
β-oxidation and transformed into ketone bodies due to the
absence of carbohydrate (Schonfeld and Wojtczak, 2016). FA
and ketone bodies are then transported across the BBB where
they can be used as an energy source. The generation of ketone
bodies provides astrocytes and neurons with energy sources
that can be more efficiently used than glucose (Zhang et al.,
2013). Further β-hydroxybutyrate has been shown to inhibit
astrocyte glucose consumption in mouse astrocyte culture and
consequently increase glucose neuronal availability (Valdebenito
et al., 2016). Carneiro et al. (Carneiro et al., 2016) has shown that
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infusion of ketone bodies though the carotid artery in direction
of the brain without elevating circulating blood ketone bodies
transiently increases food intake and alter energy homeostasis.
This paradigm reproduces the effects of ketones during fasting
condition, confirming that ketone bodies levels can be detected
by the brain to modify peripheral energy homeostasis. However,
none of these studies have assessed if these ketone bodies
can be produced by the brain per se when FA are in excess
during HFD intake.
Hence, when energy intake is abundant and particularly rich in
lipids, hypothalamic astrocytes can then produce ketone bodies
from FA (Blazquez et al., 1999; Guzman and Blazquez, 2004;
Escartin et al., 2007; Le Foll et al., 2014). Many studies have
shown that astrocytes are the major brain site of FA oxidation
and the only possible source of ketone body production in the
brain (Edmond et al., 1987, 1998; Blazquez et al., 1999). During
fasting or when blood glucose levels are low, FFA levels are
elevated and are metabolized by astrocytes (Edmond et al., 1987)
they then enter the mitochondria and undergo β-oxidation to
provide ATP to adjacent neurons (Edmond et al., 1987; Pocai
et al., 2006). During HFD feeding, i.e., when energy intake and
FA are in excess, hypothalamic astrocytes can also produce ketone
bodies (Edmond et al., 1987; Blazquez et al., 1999; Guzman and
Blazquez, 2004; Le Foll et al., 2014). 3-hydroxy-3-methylglutaryl-
CoA (HMG-CoA) synthase and HMG-CoA lyase are the rate-
limiting enzyme involved in this process (Hegardt, 1995, 1998).
During low-fat diet (LFD; 13.5% fat as percent of total energy
intake) and after a 24 h fast, hypothalamic ketone bodies levels
are ∼20 µM, whereas the FFA levels are ∼37 µM while their
serum levels are ∼350 and ∼300 µM respectively (Le Foll et al.,
2014; Figure 1A). However, when lean rats are fed a 60% HFD for
several days on restricted intake schedule (3 h per day of feeding
and 21 h of fasting), VMH FFA levels reach a concentration of
∼ 22.5 µM, which is lower than what was measured during LFD
intake (Le Foll et al., 2014). On 60% HFD and using the restricted
schedule paradigm, VMH ketone levels spike to ∼100 µM 1 to
2 h after the onset of feeding (Le Foll et al., 2014). To explain this
difference in VMH FFA levels between LFD and HFD, we could
hypothesize that during HFD intake, FA are uptaken at a greater
rate by astrocytes which then metabolize them into ketone bodies.
The monocarboxylate transporter 1 (MCT1) allows for the export
of ketone bodies out of astrocytes, which can be uptaken into
neurons by MCT2 (Simpson, 1978; Edmond et al., 1987; Auestad
et al., 1991; Edmond, 1992). In neurons, ketone bodies are then
metabolized in the mitochondria to produce ATP (McKenna,
2012; Brekke et al., 2015). Importantly, the incubation of VMH
primary neurons with ketone bodies overrides CD36-mediated
FA sensing (Le Foll et al., 2009a) leading us to believe that under
HFD condition, ketone bodies sensing is more important than FA
sensing (Figure 1B).
Aside from astrocytes, a crucial role for another type of
glial cell, tanycytes, has emerged (Chowen et al., 2013; Langlet
et al., 2013; Hofmann et al., 2017). These tanycytes line the
third ventricle along the hypothalamus and mediate the exchange
between the cerebrospinal fluid and adjacent brain areas such as
the ARC. Tanycytes send their processes to ARC neurons and
astrocytes establishing a “metabolic sensing unit” (Bolborea and
FIGURE 1 | Hypothetical working model between CD36-mediated neuronal
fatty acid (FA) sensing and astrocyte-produced ketone bodies during low fat
diet (LFD) and high fat diet (HFD) intake. (A) LFD intake- FA crossing the blood
across the blood-brain barrier (BBB) are taken up and oxidized by astrocytes
to produce ATP while FA bind to FAT/CD36 located on metabolic sensing
neurons in the ventromedial hypothalamus (VMH = VMN + ARC). Their
excitation or inhibition activates store-operated Ca2+ channels (SOCC) which
depolarize or hyperpolarize the neuron. (B) After a short-term HFD intake,
brain extracellular FA levels are decreased compared to LFD intake due to an
increase in FA flux into VMH astrocytes to generate ketone bodies. Ketone
bodies are exported via MCT1 and taken up by neurons via MCT2. Ketone
bodies are utilized by the neurons and produce ATP and ROS in excess. ATP
and ROS are hypothesized to override CD36-mediated FA sensing which
activate or inhibit the KATP channel. (C) Long term HFD intake induces as
astrogliosis and microglial inflammation. These cytokines might interfere with
the astrocyte-neuronal communication leading to disturbances in the control
of food intake promoting continued hyperphagia on HFD. Adapted from Le
Foll and Levin (2016).
Dale, 2013). Using genetically modified mice and fluorescent FA,
tanycytes have been shown to preferentially uptake OA vs. PA
and OA labeling was found along the tanycytes processes inside
the ARC. HFD-feeding altered the uptake of FA in mice with
OA and PA showing a similar distribution pattern. Additionally,
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both were only detected in the tanycyte layer and not in the
ARC (Hofmann et al., 2017). Together these studies highlight
the important role of tanycytes in uptaking FA in the medio-
basal hypothalamus and connecting to different cell type to
possibly alter hypothalamic FA sensing. How astrocytes and
tanycytes send their information to adjacent neurons and how
a specific type/quantity of circulating brain FA can alter this
communication and the neuronal activity to control food intake
and metabolism remains to be determined.
How Do Astrocytes Regulate Food
Intake During HFD Feeding?
To further understand the role of hypothalamic astrocyte-derived
ketone bodies in the regulation of food intake, male
Sprague-Dawley rats were trained to eat all of their daily
caloric intake on a LFD or 60% HFD for 3 h/day in order to
artificially increase their FA levels. Rats fit with a jugular catheter
and VMH microdialysis probe were allowed to eat for 24 h on the
testing day. Food intake, serum and VMH ketone or FFA levels
were assessed over a 6 h period after dark onset (Le Foll et al.,
2014). Over the first 3 h, LFD and HFD-fed rats ate the same
amount of calories, however, during the second 3 h period after
dark onset, HFD-fed rats ate 50% less and consumed fewer meals
than LFD-fed rats. As mentioned in the previous paragraph,
extracellular VMH FA levels were lower in HFD than LFD rats
during the entire 6 h period (Le Foll et al., 2014). Alteration of
gene transcription or translation, or the secretion of anorexic gut
hormones could explain the underlying mechanism by which this
early spike in VMH ketones might induce this delayed decrease
food intake. Nevertheless, the pharmacological inhibition of
VMH astrocyte ketone production fully restored the intake of
HFD to the same levels as LFD during the second 3 h time-period
after feeding onset (Le Foll et al., 2014). The intracellular
mechanism by which VMH ketone bodies production might
alter the activity of VMH neurons responsible for mediating
food intake is not fully understood. Using Ca2+ imaging to
assess the activity of primary VMH neurons, we showed that
ketones bodies are able to override CD36-mediated FA sensing
in VMH neurons by exciting neurons that were already activated
or inhibited by FA (Le Foll et al., 2009a). Thus, we hypothesize
that the excitatory effect induced by an excess of ketone bodies
provokes an overproduction of ATP or ROS (Paeger et al., 2017)
by the neuronal mitochondria that overrides the CD36-mediated
FA sensing mechanism, but this hypothesis remains to be tested
(Le Foll and Levin, 2016; Figure 1C).
To further understand the effect of ketone bodies on food
intake when overweight, ketone bodies levels were measured in
DIO and DR rats. Indeed when DIO and DR rats are switched
from LFD to HE diet, both become hyperphagic for 3 days (Levin
et al., 1997). However, after 3 days on HE diet, DIO rats remain
hyperphagic while DR rats lower their intake to their LFD levels
(Levin and Dunn-Meynell, 2002; Levin et al., 2003). Even though
VMH ketone body levels on the third day of HE diet intake
were similar in DIO and DR after dark onset feeding, only DR
rats reduced their food intake (Le Foll et al., 2015b). To validate
the hypothesis that the reduction of food intake in DR rats on
the third day of HE diet intake is due to an increase in VMH
ketone bodies level, local astrocyte VMH ketone production was
inhibited for 2 h prior to feeding using reverse microdialysis.
This inhibition completely reversed their reduced food intake
and drastically increased their total daily food intake (Le Foll
et al., 2015b), suggesting that DR FA sensing neurons are more
sensitive to the overriding effects of ketone bodies on normal
CD36-mediated FA sensing than DIO rats. In concert, these
results suggest that the hyperphagia observed in HE diet-fed DIO
rats might originate in a defective VMH FA and ketone neuronal
sensing. In addition, the hyperphagia observed in HE diet-fed
DIO rats might also be due to the increase in leptin levels that
occurs on the third day of HE diet intake (Levin et al., 2003),
resulting in the development of obesity (Park et al., 2011). Finally,
given the fact that ketone bodies and CD36-FA sensing control
food intake and energy homeostasis through VMH neurons and
that these neurons control many physiological processes, we
could hypothesize that alteration of neuronal sensing by ketone
bodies might alter gut hormone secretion, sympathetic nervous
system activity in adipose depots, liver and/or muscle and/or
efferent vagal activity to liver and pancreas. Thus, while the
short-term inhibitory effects of HFD on feeding appear to be
orchestrated by a neuronal-astrocyte coupling, the HFD-induced
long-term hyperphagia observed in animals and people may be
due additional factors as obesity progressively develops and glial
inflammation seems to be one of the main candidate (Figure 1).
Indeed, we could hypothesize that HE diet induce astrogliosis in
DIO rats but not in DR rats or that DR rats metabolic sensing
neurons are more responsive to signals sent by their adjacent
astrocytes (Le Foll and Levin, 2016).
Role of Inflammation
Glial cells constitute around 50% of the total cells in the whole
brain (Azevedo et al., 2009; Keller et al., 2018). Glial cells
are mainly composed of astrocytes, tanycytes and microglia.
As mentioned above, these glial cells create major connections
to adjacent neurons and are critical regulators of neuronal
activity, especially in the regulation of nutrient uptake and
metabolism. The hypothalamic neuronal circuitry, in particular,
is highly responsive to obesogenic diets. Indeed, in response
to HFD, astrocytes and microglia can proliferate and develop
a hypertrophic and reactive phenotype called gliosis (Horvath
et al., 2010), which is characterized by the upregulation of
specific structural protein such as glial fibrillary acidic protein
(GFAP) and ionized calcium binding adaptor molecule 1 (Iba1),
respectively (Le Thuc et al., 2017; Avalos et al., 2018). They then
produce inflammatory mediators such as TNF-α, IL-1β, IL-6 (De
Souza et al., 2005; Garcia-Caceres et al., 2013) and CX3CL1 (only
microglia) (Morari et al., 2014). Obese rodents exhibit increased
levels of inflammatory cytokines within the hypothalamus
(Garcia-Caceres et al., 2013). One possible hypothesis is that
this state of low grade inflammation precedes the development
of obesity (Le Thuc et al., 2017) and hence plays a causal role,
however, the opposite could also be possible. Thaler et al. (2012)
has shown that a single day of HFD is sufficient to increase
cytokine production in mice whereas others have shown that
this requires at least 3 days of HFD intake (Scherer et al., 2012).
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IKKβ (inhibitor of nuclear factor kappa-B kinase subunit beta)
seems to be the major mediator in regulating this glial activation
and the subsequent secretion of inflammatory cytokines (Zhang
et al., 2008; Douglass et al., 2017). Furthermore, treatment
with IL-6 neutralizing antibodies in the hypothalamus improved
insulin action in the brain of rodents fed HFD (Sartorius et al.,
2012). The inhibition of CX3CL1 in the hypothalamus reduced
inflammation, adiposity and glucose intolerance, suggesting that
CX3CL1 could mediate the early recruitment of microglia by
HFD and thus participate in the induction of the hypothalamic
inflammatory response (Morari et al., 2014). Moreover, the
combination of high carbohydrate and HFD has been shown
to provoke a higher inflammatory response compared to HFD
alone (Gao et al., 2017a). Until now, however, it is unknown how
HFD-mediated inflammation affects astrocyte-neuronal coupling
and modulates hypothalamic FA sensing.
FA AND REWARD
In addition to their effect on food intake, FA also exert rewarding
properties that vary depending on their type and quantity
ingested (Fulton and Alquier, 2018). Reward behaviors can
be separated into “liking,” “wanting” and “learning” (Berridge
et al., 2009). Reward signals can override homeostatic signals
and for example, even satiated after a rich meal, dessert or
sweets still sound appealing (Derman and Ferrario, 2018).
The mesolimbic system controls reward and feeding behaviors
(Cansell and Luquet, 2016) and connects major nuclei involved
in reward processes. The VTA neurons project to the NAc
as well as to the amygdala and the hippocampus to trigger
the release of dopamine (Gardner, 2005). Dopamine is often
released in response to motivationally relevant stimuli (Ranaldi,
2014; Holly and Miczek, 2016). Prolonged HFD intake rich in
saturated FA decreases this dopamine release in rats and is
associated with deficits in the reward system (Schultz, 2002;
Stice et al., 2008; Johnson and Kenny, 2010; Michaelides et al.,
2012), while a HFD rich in monounsaturated FA such as OA
has a protective effect (Hryhorczuk et al., 2018). The lingual
application of linoleic acid increased NAc dopamine levels in
rats (Adachi et al., 2013) and increased brain c-Fos neuronal
activation in the VTA and amygdala (Peterschmitt et al., 2018).
Furthermore, excessive intake of saturated fat promotes anxiety
and depressive behaviors resulting from neuroinflammatory
responses induced by HFD feeding in the NAc (Decarie-Spain
et al., 2018). Finally, the depletion of LPL in the NAc increased
palatable food preference and food-seeking behavior in chow-
diet fed mice injected with TG emulsion in the carotid toward
the brain (Cansell et al., 2014). To further assess the role
of FA on reward, it would be of interest to study the role
of dietary polyunsaturated FA, such as linoleic, EPA or DHA
(Hryhorczuk et al., 2016), and determine if these FA induce
positive rewarding responses compared to saturated FA. In
conclusion, in addition to FA control of food intake, FA exert
multiple actions in the brain that all together can regulate food
intake and eating behaviors.
CONCLUSION AND PERSPECTIVES
In conclusion, the metabolic sensing unit composed by neurons,
astrocytes and tanycytes in the medio-basal hypothalamus
is, in part, responsible for the control of food intake and
energy homeostasis. Many FA receptors (FAT/CD36, GPCRs)
and enzymes (LPL, CPT1) have shown their importance in
these metabolic processes. Nevertheless, many questions remain.
Do astrocytes send direct signal to neurons through their
foot processes? Does inflammation affect neuronal FA sensing
and astrocytes ketone bodies production during HFD feeding?
Answering these questions would give a better understanding on
how the VMH astrocytes and neurons communicate to control
food intake and regulate energy homeostasis.
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